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BenzohydrazideAbstract The crystal structure of 2-amino-N0-[(1Z)-1-(4-chlorophenyl)ethylidene]benzohydrazide
(I) is determined by X-ray diffraction at room temperature. The structure of I also was character-
ized by elemental analysis, mass, FT-IR and NMR spectroscopic techniques. The compound crys-
tallizes in triclinic system, and space group is P1. Unit-cell dimensions are the following:
a= 7.05380(10) A˚, b= 7.65490(10) A˚, c= 13.7094(4) A˚, V= 694.01(2) A˚3, Z= 2. The title com-
pound is nearly planar and has intermolecular N–H  O hydrogen bonding. According to the spec-
tral data, I exhibits an amide-iminol tautomerism.
ª 2012 King Saud University. Production and hosting by Elsevier B.V. All rights reserved.1. Introduction
The hydrazones constitute an important class of biologically
active molecules, which have attracted attention of medicinal
chemists due to their wide ranging pharmacological properties
and their potential application as antitumor, antiviral and
antiinﬂammatory agents (Jimenez-Pulido et al., 2008; Rollas
and Ku¨c¸u¨kgu¨zel, 2007; Abadi et al., 2003; Terziog˘lu and
Gu¨rsoy, 2003; Todeschini et al., 1998; Abdel-Aal et al., 2006).For example, several hydrazones and hydrazides of isoniazid
had shown good activity against tubercular, fungal, bacterial
and mycobacterial infections (Joshi et al., 2008; Shah et al.,
1985; Rollas and Ku¨c¸u¨kgu¨zel, 2007; Vigorita et al., 2001;
Ku¨c¸u¨kgu¨zel et al., 1999; Cocco et al., 1999; Sriram et al.,
2005). Some of hydrazones exhibited potential in vitro leishman-
icidal activity (Khan et al., 2003). It was reported that substituted
N0-(2-oxoindolin-3-ylidene)-benzohydrazides, isatin derivatives,
had apoptosis inducers as potential anticancer agents. (Apopto-
sis, or program cell death, plays a crucial role in normal cell
development and tissue homeostasis) (Sirisoma et al., 2009).
Structural characterization of benzohydrazides is important
to comprehend their effect mechanisms because of their con-
siderable biological effects. Herewith, recently, the crystal
structures of hydrazone compounds have been widely studied
(Weng and Zhao, 2009; Fun et al., 2008; Ali et al., 2007; Zhi
and Yang, 2007). In the present study, 2-amino-N0-[(1Z)-1-
(4-chlorophenyl)ethylidene]benzohydrazide (I, C15H14ClN3O;
Scheme 1) was synthesized and characterized by means of
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Scheme 1 Synthesis of the title compound.
Figure 1 The molecular structure of I. Displacement ellipsoids are plotted at the 50% probability level.
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ture of I was investigated by X-ray diffraction.
2. Experimental
2.1. Materials
Analytical data were obtained with a Thermo Finnigan Flash
EA 1112 analyzer. Melting point was determined in open glass
capillary using Gallenkamp melting-point apparatus. 1H- and
13C-NMR spectra were run on a Varian Unity Inova 500
NMR spectrometer. The residual DMSO-d6 signal was also
used as an internal reference. FT-IR spectra were recorded
in KBr disks on a Schimadzu IR Prestige-21 FT-IR spectrom-
eter. The Electron Spray Ionization-Mass Spectroscopy (ESI-
MS) analyses were carried out in positive ion modes using a
Thermo Finnigan LCQ Advantage MAX LC/MS/MS. CHN
analysis was carried out using Perkin Elmer 2400 CHN/O
Analyzer.NH2
O
NH
N
CH3
Cl
edima
Scheme 2 Amide-iminol tautom2.2. Synthesis of I
A mixture of 2-aminobenzohydrazide (200 mg, 10 mmol) and
p-chloroacetophenone (2 mL, 19.4 mmol) was stirred over sil-
ica gel for 18 h at room temperature (Scheme 1). After comple-
tion of the reaction as indicated by TLC, the product was
extracted with acetone. Excess of solvent was evaporated un-
der reduced pressure and the product (I) left was recrystallized
from ethanol.
Colorless single crystals of I, suitable for X-ray analysis
were obtained. Yield 62%, m.p. 164–167 C. CHN analysis:
Found: C, 62.12; H, 5.14; N, 14.45. Calc. for C15H14ClN3O
(MW: 287.74 g/mol); C, 62.61; H, 4.90; N, 14.60%. FT-IR:
(cm1) 3340 (m, br, OH, tautomeric) 3278, 3227 (w, NH),
1650 (s, C‚O), 1560 (m, sharp C‚C), 1487 (s, C‚C–C
cong.), 1218 (m, C–O,C–N), 1089 (s, C–C), 743 (s, oopCHarom).
1H-NMR (500 MHz, DMSO) dH, ppm: 10.52 (s, 1H, OH/NH
tautomer), 7.83 (d, J= 8.3, 2H, Ar-H), 7.54 (d, J= 7.8, 1H,
Ar-H), 7.47 (dd, J= 7.3, 1.5, 2H, Ar-H), 7.19 (d-t, J= 8.3,NH2
N
HO
N
CH3
Cl
lonimI
erism in the title compound.
Table 2 Hydrogen bond geometry (A˚, o) for I.
D–H  A d(D–H) d(H  A) d(D  A) \DHA
N1–H2  O1i 0.880 2.318 3.198 176.5(2)
Symmetry code: (i) +x,+y,+z.
Table 1 Crystal and experimental data and reﬁnement of the
crystal structure.
Empirical formula C15H14ClN3O
Formula weight 287.75
Crystal system Triclinic
Space group P1
Unit cell dimensions (A˚, ) a= 7.05380(10), b= 7.65490(10)
c= 13.7094(4), b= 81.402(8)
Cell volume (A˚3) 694.01(2)
Z, Calculated density (g/cm3) 2, 1.377
F(000) 300
Crystal size (mm) 0.50 · 0.40 · 0.10
Linear absorption coeﬃcient (l) 2.7 cm1
No. of observations (I> 3.00r(I)) 2517
Reﬁnement method Full-matrix least-squares on F
Goodness of ﬁt indicator 1.076
Index ranges 9 6 h 6 9, 10 6 k 6 10,
19 6 l 6 19
h range for data collection () 2.8–30.5
Data collection CRYSTALCLEAR
R (I> 3r(I)) 0.064
Rw (I> 3r(I)) 0.078
Largest diﬀ. peak and
hole (e/A˚3)
0.42 and 0.37
42 M. Arfan et al.7.3. 1.5, 1H, Ar-H), 6.75 (dd, J= 8.3, 1.0, 1H, Ar-H), 6.57
(d-t, J= 8.3, 7.8, 1.0, 1H, Ar-H), 6.18 (s, br, 2H, NH2), 2.32
(s, 3H, CH3).
13C-NMR (APT; 125 MHz, DMSO) dC, ppm:
150.27 (quaterner, C‚O), 137.81 (quaterner, C‚N), 134.64
(quaterner, C–N), 132.73 (CH), 129.82 (CH), 129.05 (CH),
128.76 (CH), 116.95 (CH), 115.50 (CH), 115.37 (quaterner),
14.85 (CH3). Mass spectra, (ESI+) m/z: 286.5 (100%;
[M1]+; 35Cl), 288.5 (27.6%; [M+1]+; 37Cl), 287.6 (15.7,
M+).Table 3 Selected bond lengths (A˚) and angles (o) for I.
Bond Dist. Bond
Cl1–C13 1.742(3) O1–C7
N3–N2 1.379(3) N3–C8
C8–C10 1.486(3) C8–C9
C1–C[2] 1.412(3) C1–C6
C10–C15 1.396(3) C11–C12
C13––C14 1.370(4) C3–C4
C13–C12 1.376(3) C15–C14
Angle () Angle ()
N2–N3–C8 116.8(2) C7–N2–N3
C10–C8–N3 115.4(2) C9–C8–N3
C1–C7–N2 115.4(2) O1–C7–N2
C6–C1–C7 116.2(2) C11–C1–0C8
C3–C2–N1 120.1(2) N1–C2–C1
C14–C13–Cl1 119.7(2)2.3. Crystallography
Diffraction measurements were carried out at 20 ± 1 C on a
Rigaku RAXIS RAPID imaging plate area detector with
graphite monochromated Mo-Ka radiation (k= 0.71070 A˚),
with a distance of 127.40 mm between the crystal and the
detector (Istanbul University Advanced Analyses Laboratory).
For the structure solution, 53310 reﬂections were collected,
4084 were unique (Rint = 0.043); equivalent reﬂections were
merged. An empirical absorption correction was applied which
resulted in transmission factors ranging from 0.71 to 1.00. The
data were corrected for Lorentz and polarization effects.
The structure of I (Fig. 1) was solved by direct methods
(SIR92) (Altomare et al., 1994) and expanded using Fourier
techniques. The non-hydrogen atoms were reﬁned anisotropi-
cally. H atoms were treated as riding, with C–H = 0.95 A˚
and Uiso(H) = 1.2Ueq(C). All calculations were performed
using the CrystalStructure (CrystalStructure, 2000) crystallo-
graphic software package. Crystallographic data for the struc-
ture reported in this paper have been deposited at the
Cambridge Crystallographic Data Centre (CCDC no. 742731).
3. Results and discussion
The analytical, physicochemical and spectral data of I are pre-
sented in Experimental Section.
3.1. Spectroscopy
The medium intensity broad band in the IR spectrum of the
target compound indicated the presence of OH group while
weak band at 3278 and 3227 cm1 conﬁrm the presence of sec-
ondary amine. The presence of OH band is indicative of the
possible tautomerization (Scheme 2) in I. Strong band at
1650 cm1 indicated the presence of amide moiety also and
thus further supports the existence of the two possible tautom-
ers with the amide tautomer as the dominant one. The pres-
ence of sharp band at 1487 cm1 indicated the presence of
conjugated carbon–carbon double bond as a characteristic
band of aromatic system while a strong absorption peak at
743 cm1 was assigned to C–Cl bond absorption frequency.Dist. Bond Dist.
1.232(2) N1–C2 1.396(3)
1.284(2) N2–C7 1.349(2)
1.492(3) C7–C1 1.493(3)
1.390(3) C10–C11 1.397(3)
1.383(4) C2–C3 1.401(4)
1.366(4) C6–C5 1.382(4)
1.387(4) C4–C5 1.394(5)
Angle ()
119.6(2) C10–C8–C9 120.6(2)
124.0(2) C1–C7–O1 122.0(2)
122.5(2) C2–C1–C7 123.9(2)
120.2(2) C15–C10–C8 121.6(2)
122.4(2) C12–C13–Cl1 119.0(2)
Table 4 Selected torsion angles () for I.
C8–N3–N2–C[7] 177.9(2) N2–N3–C8–C10 179.9(2)
N3–N2–C7–O[1] 2.6(3) N3–N2–C7–C1 179.4(2)
N3–C8–C10–C11 17.2(3) N3–C8–C10–C15 160.8(2)
C9–C8–C10–C11 162.2(2) C9–C8–C10–C15 19.8(3)
O1–C7–C1–C[2] 154.3(2) O1–C7–C1–C[6] 27.1(3)
N2–C7–C1–C[2] 28.9(3) N2–C7–C1–C[6] 149.7(2)
C7–C1–C2–N[1] 5.6(3) C7–C1–C2–C[3] 174.0(2)
C6–C1–C2–N[1] 175.8(2) C6–C1–C2–C[3] 4.5(3)
C8–C10–C11–C12 177.5(2) C8–C10–C15–C14 178.0(2)
N1–C2–C3–C[4] 177.2(2) Cl1–C13–C12–C11 179.2(2)
Figure 2 Unit cell packing diagram for I; molecular overlap view
from the a-axis.
Figure 3 Unit cell packing diagram for I; molecular overlap view
from the b-axis.
Figure 4 Unit cell packing diagram for I; molecular overlap view
from the c-axis.
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6.57 ppm with their characteristic proton couplings indicate
the presence of aromatic protons. The singlet at 10.52 ppm
indicates the presence of an amide-iminol tautomerism in the
target molecule, while a singlet at 2.32 ppm represented the
presence of CH3. The broad singlet (2H) at 6.18 ppm isassigned to NH2 protons. From the spectral data, it is con-
cluded that I involves tautomerism in solution phase (in
DMSO) with the amide form being a dominant tautomer
which crystallizes out.
The elemental analysis and the mass spectral data further
support the structure of I.
3.2. X-ray analysis
The crystal data and details of data processing are given in
Table 1. Table 2 contains the hydrogen bond geometry param-
eters. Selected bond lengths and angles are given in Table 3;
some torsion angles are given in Table 4.
ORTEP-III view of the molecular structure of the title com-
pound is given in Fig. 1. The unit cells of I are shown in Figs. 2
(view from the a-axis), 3 (view from the b-axis) and 4 (view
from the c-axis).
There is an intermolecular N–H  O hydrogen bond
(Table 2) in the molecule. The hydrogen bonding data is in
agreement with the literature (Zhi and Yang, 2007; Ban and
Li, 2008a,b; Ban and Li, 2008b; Shan et al., 2008; Zhen and
Han, 2005a,b; Jing et al., 2005; He and Liu, 2005). The crystal
structure is stabilized by intermolecular hydrogen bonding.
In the title compound, all bond lengths are within normal
ranges (Shan et al., 2008; Zhen and Han, 2005a; Jing et al.,
2005; He and Liu, 2005; Zhen and Han, 2005b). The
C8‚N3 bond length of 1.284(2) A˚ conforms to the value for
a double bond. The bond length of 1.349(2) A˚ between N2
and C7 is greater than the value for a double bond, and less
than the value for a single bond, because of conjugation in
the molecule.
4. Conclusions
Benzohydrazides are a kind of important compounds because
of their considerable biological effects. In this study, 2-amino-
N0-[(1Z)-1-(4-chlorophenyl)ethylidene]benzohydrazide (I) was
synthesized and characterized by elemental analysis, mass,
FT-IR and NMR spectroscopic techniques. In addition, the
crystal structure of I was determined by X-ray diffraction at
room temperature. According to the X-ray data, the title com-
pound is nearly planar and it has intermolecular N–H  O
hydrogen bonding. 1H-NMR spectral data show that I exhibits
an amide-iminol tautomerism in DMSO. The amide tautomer
is dominant at solid state and solution phases according to the
spectral data.
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